Evidence map›Paper›PMID 29740448›Full record

ReviewFrontiers in immunology2018

Working in "NK Mode": Natural Killer Group 2 Member D and Natural Cytotoxicity Receptors in Stress-Surveillance by γδ T Cells.

Bruno Silva-Santos, Jessica Strid

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 51 citations in OpenAlex.

  1. Trial
  2. γδ T cells in colorectal and liver cancer.Nature reviews. Gastroenterology & hepatology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Cancer immunotherapy by γδ T cells.Science (New York, N.Y.) · 2024
    Review
  18. Article
  19. Review
  20. The therapeutic role of γδT cells in TNBC.Frontiers in immunology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Bruno Silva-SantosInstituto de Medicina Molecular - João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
Jessica StridDivision of Immunology and Inflammation, Department of Medicine, Imperial College London, London, United Kingdom.
Imperial College London · GBUniversity of Lisbon · PT

Funding

Cancer Research UK C21010/A19788Wellcome Trust 100999/Z/13/Z
6 · The paper itself

Abstract

Natural killer cell receptors (NKRs) are germline-encoded transmembrane proteins that regulate the activation and homeostasis of NK cells as well as other lymphocytes. For γδ T cells, NKRs play critical roles in discriminating stressed (transformed or infected) cells from their healthy counterparts, as proposed in the "lymphoid stress-surveillance" theory. Whereas the main physiologic role is seemingly fulfilled by natural killer group 2 member D, constitutively expressed by γδ T cells, enhancement of their therapeutic potential may rely on natural cytotoxicity receptors (NCRs), like NKp30 or NKp44, that can be induced selectively on human Vδ1

Indexed as

Cytotoxicity, ImmunologicAnimalsHumansKiller Cells, NaturalLymphocyte ActivationMiceNatural Cytotoxicity Triggering Receptor 2Natural Cytotoxicity Triggering Receptor 3NK Cell Lectin-Like Receptor Subfamily KReceptors, Antigen, T-Cell, gamma-deltaT-LymphocytesKLRK1 protein, humanKlrk1 protein, mouseNatural Cytotoxicity Triggering Receptor 2Natural Cytotoxicity Triggering Receptor 3NCR2 protein, humanNCR3 protein, humanNK Cell Lectin-Like Receptor Subfamily KReceptors, Antigen, T-Cell, gamma-deltaimmunotherapynatural cytotoxicity receptorsnatural killer cell receptorsnatural killer group 2 member Dγδ T cells

Identifiers

PMID29740448
PMCPMC5928212
OpenAlexW2800902111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.